A new book is challenging the long-held assumption that little can be done for the more than 55 million people worldwide living with dementia beyond managing symptoms. Mark L. Fox, founder of Resona Health and a former aerospace engineer, has released 'The Memory Room: A New Way to Create Clarity, Calm, and Connection in Assisted Living,' which explores the science behind cognitive variability and non-pharmacological interventions that may help individuals experience more moments of clarity and engagement.
Drawing on research from MIT's Picower Institute for Learning and Memory and clinical findings from a completed Phase 1 study, Fox argues that the 'good days' observed by caregivers and families are not random events but may reflect measurable changes in neural function that can be supported through safe, non-invasive interventions. 'Anyone who has spent time in memory care has seen it,' said Fox. 'A resident who suddenly remembers a family member's name. A conversation that lasts twenty minutes when it normally lasts two. A moment when someone seems more present, more connected, and more themselves. The question is no longer whether these moments happen. The question is whether we can help create the conditions that allow them to happen more often.'
The book focuses on 40 Hz gamma stimulation, an area of neuroscience that gained international attention following MIT studies demonstrating that stimulation at 40 cycles per second may influence biological processes associated with brain health, including microglial activation, glymphatic function, and neural network coordination. At the center of the discussion is BlueVibe, a wearable device developed by Resona Health that combines pulsed electromagnetic field (PEMF) technology and pulsed blue light stimulation at 40 Hz.
The book presents results from a completed six-week Phase 1 study involving 41 participants. According to the study, all 41 participants demonstrated improvement in measured cognitive function scores, with no regression and no adverse effects reported. Statistical analysis produced a p-value of less than 0.000001. Fox emphasizes that neither BlueVibe nor any existing technology should be viewed as a cure for Alzheimer's disease or dementia. 'This is not a book about curing dementia,' Fox explained. 'It's a book about supporting the brain's remaining capacity. It's about helping residents access more of the abilities they still have. It's about creating more opportunities for connection, communication, and quality of life.'
'The Memory Room' is written for assisted living operators, memory care directors, nursing leaders, healthcare administrators, clinicians, caregivers, and families seeking practical, evidence-informed approaches to supporting cognitive function. Healthcare leaders may find particular relevance in the book's discussion of non-drug interventions, implementation challenges in senior living environments, caregiver burnout, family satisfaction, and the growing demand for innovative memory care solutions. Early readers have described the book as both scientifically accessible and emotionally compelling, combining neuroscience, real-world caregiver experiences, and practical implementation strategies into a vision for the future of memory care.
The book is available now on Amazon. For more information about Resona Health and BlueVibe, visit resona.health.
